Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment

European Journal of Neurology

Volumn 17, Issue 12, 2010, Pages 1428-1436

  Valko, P O ^a   Waldvogel, D ^a   Weller, M ^a   Bassetti, C L ^a,c   Held, U ^b   Baumann, C R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Depression; Disease duration; Dopaminergic treatment; Excessive daytime sleepiness; Fatigue; Idiopathic Parkinson's disease

Indexed keywords

CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENTACAPONE; LEVODOPA; PERGOLIDE; PRAMIPEXOLE; ROPINIROLE;

ADULT; AGED; ARTICLE; BECK DEPRESSION INVENTORY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SCORING SYSTEM; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; AGED, 80 AND OVER; DEPRESSION; DISORDERS OF EXCESSIVE SOMNOLENCE; DOPAMINE AGONISTS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX;

EID: 78649588265     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03063.x     Document Type: Article

References (53)

1. Friedman JH, Friedman H. Fatigue in Parkinson's disease: a nine-year follow-up. Mov Disord 2001; 16: 1120-1122.
2. Brañas P, Jordan R, Fry-Smith A, et al. Treatments for fatigue in multiple sclerosis: a rapid and systematic review. Health Technol Assess 2000; 4: 1-61.
3. Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs 2004; 64: 1295-1304.
4. Choi-Kwon S, Han SW, Kwon SU, et al. Poststroke fatigue: characteristics and related factors. Cerebrovasc Dis 2005; 19: 84-90.
5. Staub F, Bogousslavsky J. Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 2001; 12: 75-81.
6. Baumann CR, Werth E, Stocker R, Ludwig S, Bassetti CL. Sleep-wake disturbances 6 months after traumatic brain injury: a prospective study. Brain 2007; 130: 1873-1883.
7. Frucht S, Rogers JD, Greene PE, Gordon MF, Fahn S. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999; 52: 1908-1910.
8. Schapira AH. Sleep attacks (sleep episodes) with pergolide. Lancet 2000; 355: 1332-1333.
9. Hauser RA, Gauger L, Anderson WM, Zesiewicz TA. Pramipexole-induced somnolence and episodes of daytime sleep. Mov Disord 2000; 15: 658-663.
10. Hobson DE, Lang AE, Martin WRW, Razmy A, Rivest J, Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson Disease. JAMA 2002; 287: 455-463.
11. Schenkman M, Wei Zhu C, Cutson TM, Whetten-Goldstein K. Longitudinal evaluation of economic and physical impact of Parkinson's disease. Parkinsonism Relat Disord 2001; 8: 41-50.
12. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001; 16: 507-510.
13. Karlsen K, Larsen JP, Tandberg E, Jørgensen K. Fatigue in patients with Parkinson's disease. Mov Disord 1999; 14: 237-241.
14. Friedman J, Friedman H. Fatigue in Parkinson's disease. Neurology 1993; 43: 2016-2018.
15. Lou JS, Kearns G, Oken B, Sexton G, Nutt J. Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 2001; 16: 190-196.
16. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale. Eur J Neurol 2002; 9: 595-600.
17. Abe K, Takanashi M, Yanagihara T. Fatigue in patients with Parkinson's disease. Behav Neurol 2000; 12: 103-106.
18. Hagell P, Brundin L. Towards an understanding of fatigue in Parkinson disease. J Neurol Neurosurg Psychiatry 2009; 80: 489-493.
19. Alves G, Wentzel-Larsen T, Larsen JP. Is fatigue an independent and persistent symptom in patients with Parkinson disease? Neurology 2004; 63: 1908-1911.
20. Rye DB, Bliwise DL, Dihenia B, Gurecki P. Daytime sleepiness in Parkinson's disease. J Sleep Res 2000; 9: 63-69.
21. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord 1999; 14: 922-927.
22. Adler CH, Thorpy MJ. Sleep issues in Parkinson's disease. Neurology 2005; 64(Suppl.): 12-20.
23. Friedman JH, Chou KL. Sleep and fatigue in Parkinson's disease. Parkinsonism Relat Disord 2004; 10(Suppl.): 27-35.
24. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
25. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992; 42: 1142-1146.
26. Fahn S, Elton RL and the members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Liebermann A, eds. Recent Development in Parkinson's Disease. Florham Park, NJ: MacMillan Health Care Information, 1987: 153-163.
27. Hoehn MH, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427-442.
28. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the Fatigue Severity Scale in a Swiss cohort. Sleep 2008; 31: 1601-1607.
29. Friedman JH, Brown RG, Comella C, et al ; as the Working Group on Fatigue in Parkinson's Disease. Fatigue in Parkinson's disease: a review. Mov Disord 2007; 22: 297-308.
30. Bloch KE, Schoch OD, Zhang JN, Russi EW. German version of the Epworth Sleepiness Scale. Respiration 1999; 66: 440-447.
31. Beck AT, Ward CH, Mendelson M, Mock M, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
32. Razmy A, Lang AE, Shapiro CM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson Disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Arch Neurol 2004; 61: 97-102.
33. Cronbach LJ. Coefficient alpha and the internal structure of test. Psychometrika 1951; 16: 297-334.
34. Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U. Sleep attacks, dayime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord 2003; 18: 659-667.
35. Brodsky MA, Godbold J, Roth T, Olanow CW. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003; 18: 668-672.
36. Ondo WG, Dat Vuong K, Khan H, Atassi F, Kwak C, Jankovic J. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001; 57: 1392-1396.
37. Högl B, Seppi K, Brandauer E, et al. Increased daytime sleepiness in Parkinson's disease: a questionnaire survey. Mov Disord 2003; 18: 319-323.
38. Pittion-Vouyovitch S, Debouverie M, Guillemin F, Vandenberghe N, Anxionnat R, Vespignani H. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006; 243: 39-45.
39. Bergamaschi R, Romani A, Versino M, Poli R, Cosi V. Clinical aspects of fatigue in multiple sclerosis. Funct Neurol 1997; 12: 247-251.
40. Flachenecker P, Kümpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler 2002; 8: 523-526.
41. Gjerstad MD, Aarsland D, Larsen JP. Development of daytime somnolence over time in Parkinson's disease. Neurology 2002; 58: 1544-1546.
42. Del Dotto P, Gambaccini G, Caneparo D, Berti C, Bernardini S, Bonuccelli U. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists. Neurol Sci 2003; 24: 170-171.
43. Braak H, Del Tredici K, Rüb U, De Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
44. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain 2007; 130: 1577-1585.
45. Thannickal TC, Lai YY, Siegel JM. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 2007; 130: 1586-1595.
46. Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's Disease: a report of an NINDS/NIMH Work Group. Mov Disord 2006; 21: 148-158.
47. Dooneief G, Mirabello E, Bell K, Marder K, Stern Y, Mayeux R. An estimate of the incidence of depression in idiopathic Parkinson's disease. Arch Neurol 1992; 49: 305-307.
48. Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G. Excessive daytime sleepiness in de novo and treated Parkinson's disease. Mov Disord 2002; 17: 1026-1030.
49. Comella CL. Sleep disorders in Parkinson's disease: an overview. Mov Disord 2007; 17(Suppl.): 367-373.
50. Maria B, Sophia S, Michalis M, et al. Sleep breathing disorders in patients with idiopathic Parkinson's disease. Respir Med 2003; 97: 1151-1157.
51. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: an integral part of PD. Neurology 2002; 58: 1019-1024.
52. Ferini-Strambi L, Franceschi M, Pinto P, Zucconi M, Smirne S. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992; 38: 92-98.
53. Monaca C, Duhamel A, Jacquesson JM, et al. Vigilance trouble in Parkinson's disease: a subjective and objective polysomnographic study. Sleep Med 2006; 7: 448-453.